ABILIFY (aripiprazole) SOLUTION [Otsuka Pharmaceutical Co, Ltd]

1 INDICATIONS AND USAGE	10 OVERDOSAGE	11 DESCRIPTION
12 CLINICAL PHARMACOLOGY	13 NONCLINICAL TOXICOLOGY	14 CLINICAL STUDIES
16 HOW SUPPLIED/STORAGE AND HANDLING	17 PATIENT COUNSELING INFORMATION	2 DOSAGE AND ADMINISTRATION
3 DOSAGE FORMS AND STRENGTHS	4 CONTRAINDICATIONS	5 WARNINGS AND PRECAUTIONS
6 ADVERSE REACTIONS	7 DRUG INTERACTIONS	8 USE IN SPECIFIC POPULATIONS
9 DRUG ABUSE AND DEPENDENCE	WARNINGS: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDALITY AND ANTIDEPRESSANT DRUGS

1 INDICATIONS AND USAGE	10 OVERDOSAGE	11 DESCRIPTION
12 CLINICAL PHARMACOLOGY	13 NONCLINICAL TOXICOLOGY	14 CLINICAL STUDIES
16 HOW SUPPLIED/STORAGE AND HANDLING	17 PATIENT COUNSELING INFORMATION	2 DOSAGE AND ADMINISTRATION
3 DOSAGE FORMS AND STRENGTHS	4 CONTRAINDICATIONS	5 WARNINGS AND PRECAUTIONS
6 ADVERSE REACTIONS	7 DRUG INTERACTIONS	8 USE IN SPECIFIC POPULATIONS
9 DRUG ABUSE AND DEPENDENCE	WARNINGS: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDALITY AND ANTIDEPRESSANT DRUGS

1 INDICATIONS AND USAGE	10 OVERDOSAGE	11 DESCRIPTION
12 CLINICAL PHARMACOLOGY	13 NONCLINICAL TOXICOLOGY	14 CLINICAL STUDIES
16 HOW SUPPLIED/STORAGE AND HANDLING	17 PATIENT COUNSELING INFORMATION	2 DOSAGE AND ADMINISTRATION
3 DOSAGE FORMS AND STRENGTHS	4 CONTRAINDICATIONS	5 WARNINGS AND PRECAUTIONS
6 ADVERSE REACTIONS	7 DRUG INTERACTIONS	8 USE IN SPECIFIC POPULATIONS
9 DRUG ABUSE AND DEPENDENCE	WARNINGS: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDALITY AND ANTIDEPRESSANT DRUGS